0001824293-23-000163.txt : 20230926 0001824293-23-000163.hdr.sgml : 20230926 20230926160855 ACCESSION NUMBER: 0001824293-23-000163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230922 FILED AS OF DATE: 20230926 DATE AS OF CHANGE: 20230926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Leanne CENTRAL INDEX KEY: 0001398278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40034 FILM NUMBER: 231280559 MAIL ADDRESS: STREET 1: C/O VALLON PHARAMCEUTICALS, INC. STREET 2: 100 N 18TH STREET, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER NAME: FORMER CONFORMED NAME: Kelly Leanne M. DATE OF NAME CHANGE: 20070502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GRI BIO, Inc. CENTRAL INDEX KEY: 0001824293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824369909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (619) 400-1171 MAIL ADDRESS: STREET 1: 2223 AVENIDA DE LA PLAYA STREET 2: SUITE 208 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Vallon Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20200910 4 1 wk-form4_1695758927.xml FORM 4 X0508 4 2023-09-22 0 0001824293 GRI BIO, Inc. GRI 0001398278 Kelly Leanne C/O GRI BIO, INC. 2223 AVENIDA DE LA PLAYA, SUITE 208 LA JOLLA CA 92037 0 1 0 0 Chief Financial Officer 0 Stock Option (Right to Buy) 1.52 2023-09-22 4 A 0 83333 1.52 A 2033-09-22 Common Stock 83333 83333 D Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 36 equal monthly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant. /s/ Leanne Kelly 2023-09-26